CEACAM5 and colonic neoplasm: Chakraborty et al. observed significantly improved overall survival in mice bearing MC38-CEA+ colon tumors when treated with a 90Y radiolabeled anti-CEA antibody in combination with a CEA/TRICOM vaccine, as compared to TRT or immunotherapy monotherapy [59].